CCCC
C4 Therapeutics, Inc.
$4.30
-0.04 (-0.92%)
At close · Jul 2
Market Cap
$475.44M
Shares
110,567,222
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Program Authorized
$25,000,000
as of 2023-05-29
Cash spent on buybacks by quarter
Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2026-03-31 YTD | $200,000 | 10-Q, filed 2026-05-12 |
| 2025-12-31 | $193,000 | 10-K, filed 2026-02-26 |
| 2024-12-31 | $194,000 | 10-K, filed 2026-02-26 |
| 2023-12-31 | $110,000 | 10-K, filed 2025-02-27 |
| 2022-12-31 | $0 | 10-K, filed 2024-02-22 |
| 2020-12-31 | $194,000 | 10-K, filed 2022-02-24 |
| 2019-12-31 | $30,000 | 10-K, filed 2022-02-24 |